Brief: Pharmabcine To Conduct Capital Increase Of 26 Billion Won For Operational Funds
03/07/2024 06:55
PharmAbcine Inc 208340.KQ :
* PHARMABCINE: TO CONDUCT CAPITAL INCREASE OF 26 BILLION WON
FOR
OPERATIONAL FUNDS
Source text for Eikon: ID:
Further company coverage: 208340.KQ
Recent news on PharmAbcine
See all newsBrief: Pharmabcine Announces Safety Approval For 1st dose Cohort In Phase 1A/B Clinical Trial Of Pmc-309
Brief: Pharmabcine To Conduct Capital Increase Of 26 Billion Won For Operational Funds
Brief: Pharmabcine To Conduct Capital Increase Of 3.7 Billion Won For Operational Funds
Brief: Pharmabcine To Conduct Capital Increase Of 4.7 Billion Won For Operational Funds
Brief: PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration